Yahoo finance API is not available right now, please try again soon...

Company Spotlight UPDATE 5/15/2013

**If you would like to submit your company for consideration by our team of research experts to be profiled for a Market Caliber Company Spotlight Alert, contact the Market Caliber Team at

MARKETCALIBER: Company Spotlight UPDATE 5/15/2013

For those of you who subscribe to our Company Spotlight Alerts, you received our latest email alert this yesterday evening on May 14th, for ImmuDyne, Inc. or IMMD.

Company Spotlight Recap:

Company: ImmuDyne, Inc.
Symbol: OTC: IMMD
Stock Price*: $0.32 per share


  • Is a leading research and manufacturing biotech firm, producing nutraceutical products, a sub-industry of biotech that has been experiencing incredible market growth.
  • Specializes in products containing Beta Glucan polysaccharides, compounds that have suggested the ability to boost immune system’s performance in clinical data.
  • Owns several patents that serve to protect its exclusivity in the beta glucan product market.
  • Announced the appointment of former Veritage President and CEO, Karen Kingston, whose past clients have included numerous Fortune 500 companies such as Johnson & Johnson, Meditronic, and Pfizer, as Chief Marketing Officer.
  • Announced 15-Month plan for growth, which includes introducing new product lines and expanding into new multi-billion dollar markets.
  • Technical indicators cross the board signaling a “BUY” action, in the short, medium, and long terms.
  • Holds a unanimous “STRONG BUY” recommendation from BARCHART.COM (as of May 15, 2013)

*based on previous closing price as of the time and date of original alert


After alerting our subscribers to IMMD Wednesday evening, IMMD surged this morning to $0.41 per share to set a new 52 Week High for the second straight day for a gain of over 28% form its previous session’s closing price of $0.32!

Already on the uptrend, IMMD broke past the $0.40 mark today! As the company continues to execute on its 15-month plan for growth as outlined just this past April, IMMD could continue to test new highs, to potentially reach or surpass $0.50 plus levels in the near term!
The technical indicators are showing IMMD moving well into bullish territory with a “STRONG BUY” recommendation from BARCHART.COM
Trading more than 10 times its 3 Month Average Volume in today’s session alone, IMMD looks like it is continuing to gain momentum quickly and could be strong and steady gainer of the summer!
We are very happy to have been able to bring your attention to yet another double digit single day gainer and continue to pride ourselves on alerting our subscribers to the very best of the companies that come across our desk or are identified in the course of our research through our Company Spotlight Alerts!

Congratulation to those who moved early and were able to take advantage of IMMD’s tremendous performance today, and make sure to keep watching as it could have the legs to extend its rally far beyond today’s session and into the summer months!

So don’t miss out on our next record breaking alert and make sure to subscribe to our Company Spotlight Alerts if you haven’t already!

For our current subscribers already enjoying our alerts, we’ll be sure to continue to research the market to bring you more exciting alerts like this one!

The Market Caliber Team

Disclaimer: (Please Read Disclaimer) is engaged in the business of marketing and advertising companies. All content in this communication is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.  Never invest in any stock featured on website or email alerts unless you can afford to lose your entire investment. Many of the stocks featured are highly speculative. 
Compensation: has not been monetarily compensated by a third party for profile coverage regarding ImmuDyne, Inc.. (IMMD: OTC Markets).  We do not own any shares of IMMD. 
None of the employees are registered as investment advisors, financial analysts, brokers, or dealers in any jurisdiction whatsoever. Your use of the website, email alerts, and all other services means that you agree to hold, its operators, owners, and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may sustain. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation for the purchase or sale of any securities. The information provided is obtained from sources deemed reliable, does not guarantee in any way the timeliness, sequence, accuracy, adequacy, or completeness of such information made regarding stocks discussed on or in email alerts. The owner, publisher, editor and their associates are not responsible for errors and omissions. You understand and agree that at the time of any transaction you make, employees, affiliates, and friends and family owners and operators may have a position in such securities. The position may have been acquired prior to the publication of any website information or email alert. You should also be aware that the aforementioned parties do have the right to sell their positions at any time without further notification. Any opinions expressed are subject to change without encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or persons affiliated with or associated with such companies; or is available from public sources. Read our full disclaimer at:

Filed in: Company Spotlight, Latest

No comments yet.

Leave a Reply

You must be logged in to post a comment.